Actively Recruiting
Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial
Led by Xiyuan Hospital of China Academy of Chinese Medical Sciences · Updated on 2024-08-20
100
Participants Needed
5
Research Sites
190 weeks
Total Duration
On this page
Sponsors
X
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor
S
Suzhou Hosptial of Traditional Chinese Medicine
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is: 1. To evaluate the efficacy of Songling Xuemaikang Capsules(SLXMKC) with grade 1 hypertension. 2. To reveal the potiential effects of SLXMKC on vascular function and structure of patients with grade 1 hypertension. 3. To explore the underlying mechanisms of the therapeutic effects of SLXMKC on the intervention of grade 1 hypertension.
CONDITIONS
Official Title
Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 35 and 65 years old, male or female
- Diagnosed with grade 1 essential hypertension
- Not currently taking antihypertensive drugs regularly or have taken them irregularly in the past
- Signed informed consent form
You will not qualify if you...
- Significant liver dysfunction (ALT and AST more than twice the normal range)
- Significant kidney dysfunction (serum creatinine ≥2.0 mg/dl or eGFR <60 ml/min/1.73m2)
- Gastrointestinal diseases affecting drug absorption
- Allergy to the study medication
- Pregnant or breastfeeding women, or men planning to father a child within six months
- Other serious primary diseases or malignant tumors
- Hyperlipidemia, regardless of lipid-lowering treatment
- Presence of left ventricular hypertrophy, ankle-brachial index <0.9, carotid intima-media thickness ≥0.9 mm, or atherosclerotic plaque
- Hypertension with other serious comorbidities such as cerebrovascular disease, cardiovascular diseases, renal disease, peripheral artery disease, retinopathy, or diabetes
- Any other serious condition deemed unsuitable for the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, China, 100091
Actively Recruiting
2
Suzhou Hosptial of Traditional Chinese Medicine
Suzhou, Jiangsu, China, 215002
Not Yet Recruiting
3
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Jinan, Shandong, China, 250013
Not Yet Recruiting
4
China Academy of Chinese Medical Sciences Xiyuan Hospital Jining Hospital
Jining, Shandong, China, 272000
Not Yet Recruiting
5
China Academy of Chinese Medical Sciences Xiyuan Hospital Shanxi Hospital
Taiyuan, Shanxi, China, 030024
Not Yet Recruiting
Research Team
A
Anlu Wang, Doctor
CONTACT
Q
Qiyu Liu, Doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here